Biodesix, Inc.
Clinical trials sponsored by Biodesix, Inc., explained in plain language.
-
Blood test may spare thousands from unnecessary lung biopsies
Diagnosis OngoingThis study looks at whether a blood test called Nodify XL2 can help doctors better manage lung nodules that have a low to moderate chance of being cancer. About 2,000 adults over 40 with a solid lung nodule between 8 and 30 mm are taking part. The goal is to see if using the test…
Sponsor: Biodesix, Inc. • Aim: Diagnosis
Last updated May 22, 2026 14:04 UTC
-
Blood test may help doctors choose better lung cancer treatments
Knowledge-focused OngoingThis study tracks how doctors use the VeriStrat blood test to make treatment decisions for people with non-small cell lung cancer. Researchers will collect data from about 5,000 patients to see if the test leads to better outcomes. They will also test new experimental blood tests…
Sponsor: Biodesix, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC